Initio-DSR Capsule is a combination pharmaceutical formulation containing Domperidone 30mg and Pantoprazole 40mg, designed for the management of gastrointestinal disorders. Domperidone, a peripheral dopamine D2 receptor antagonist, facilitates gastric motility and accelerates gastric emptying, thereby alleviating symptoms such as nausea, vomiting, and bloating associated with delayed gastric emptying and gastroparesis. Pantoprazole, a proton pump inhibitor, suppresses gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, providing effective relief from acid-related disorders including gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcer disease. The combined action of Domperidone and Pantoprazole in Initio-DSR Capsule offers symptomatic relief by enhancing gastric motility while reducing gastric acidity, making it suitable for patients with concomitant motility and acid secretion abnormalities. It is recommended to be taken orally as prescribed by a healthcare professional, typically before meals to optimize therapeutic outcomes. Caution is advised in patients with known hypersensitivity to either component, cardiac arrhythmias, or severe hepatic impairment. Regular monitoring and adherence to prescribed dosage are essential to minimize potential adverse effects and ensure efficacy.